Sam Brusco, Associate Editor01.10.23
GE HealthCare has entered a deal to acquire IMACTIS, a company focused on computed tomography (CT) interventional guidance across a variety of care areas.
IMANCTIS is a France-based company founded in 2009 and created CT-Navigation, an ergonomic universal tool providing stereotactic needle guidance to enable intuitive pre-planning and continuous control throughout a range of procedures.
“We’re thrilled to take this step in strengthening our interventional guidance offering for patients and customers,” Jan Makela, president and CEO of Imaging for GE HealthCare told the press. “The IMACTIS CT-Navigation system is designed to improve workflow for interventional radiologists and hospitals by increasing procedural accuracy, while helping to reduce procedure time and radiation dose for patients and physicians. It is an innovative navigation solution for image-guided percutaneous procedures that aims for better patient outcomes, by reducing variability for simple and complex procedures and improving reproducibility.”
“The timing to join GE HealthCare is perfect,” said Pierre Olivier, president and CEO of IMACTIS. “Our solution, which is already deployed in leading healthcare systems in Europe and the U.S., is ready to scale and become a standard of care, thanks to GE HealthCare’s market access. Our product development team also sees significant opportunities to integrate our hardware and software into GE HealthCare solutions and make the workflow of the interventional radiologists and oncologists even simpler and faster.”
GE HealthCare plans to expand the technology to its image guided therapy (IGT) business to drive further growth. IMACTIS CT-Navigation includes an integrated workstation, guidance software, and disposable procedure kit and is currently approved under the European Union’s Medical Devices Regulation (MDR) and has FDA clearance. GE HealthCare is a leader in CT with a large install base and global scale, allowing opportunities for the IMACTIS CT-Navigation system at client sites.
IMANCTIS is a France-based company founded in 2009 and created CT-Navigation, an ergonomic universal tool providing stereotactic needle guidance to enable intuitive pre-planning and continuous control throughout a range of procedures.
“We’re thrilled to take this step in strengthening our interventional guidance offering for patients and customers,” Jan Makela, president and CEO of Imaging for GE HealthCare told the press. “The IMACTIS CT-Navigation system is designed to improve workflow for interventional radiologists and hospitals by increasing procedural accuracy, while helping to reduce procedure time and radiation dose for patients and physicians. It is an innovative navigation solution for image-guided percutaneous procedures that aims for better patient outcomes, by reducing variability for simple and complex procedures and improving reproducibility.”
“The timing to join GE HealthCare is perfect,” said Pierre Olivier, president and CEO of IMACTIS. “Our solution, which is already deployed in leading healthcare systems in Europe and the U.S., is ready to scale and become a standard of care, thanks to GE HealthCare’s market access. Our product development team also sees significant opportunities to integrate our hardware and software into GE HealthCare solutions and make the workflow of the interventional radiologists and oncologists even simpler and faster.”
GE HealthCare plans to expand the technology to its image guided therapy (IGT) business to drive further growth. IMACTIS CT-Navigation includes an integrated workstation, guidance software, and disposable procedure kit and is currently approved under the European Union’s Medical Devices Regulation (MDR) and has FDA clearance. GE HealthCare is a leader in CT with a large install base and global scale, allowing opportunities for the IMACTIS CT-Navigation system at client sites.
